Book contents
- Vaccines as Technology
- Vaccines as Technology
- Copyright page
- Contents
- Figures
- Acknowledgments
- Introduction
- 1 Vaccines as Instruments of Public Health
- 2 The Vaccine Development Ecosystem
- 3 Vaccine Development under Proprietary Paradigms
- 4 Access to Vaccine Technology
- 5 Aligning Vaccine Innovation with Public Health Needs
- 6 Vaccines of the Future
- Conclusion
- Index
2 - The Vaccine Development Ecosystem
Published online by Cambridge University Press: 07 April 2022
- Vaccines as Technology
- Vaccines as Technology
- Copyright page
- Contents
- Figures
- Acknowledgments
- Introduction
- 1 Vaccines as Instruments of Public Health
- 2 The Vaccine Development Ecosystem
- 3 Vaccine Development under Proprietary Paradigms
- 4 Access to Vaccine Technology
- 5 Aligning Vaccine Innovation with Public Health Needs
- 6 Vaccines of the Future
- Conclusion
- Index
Summary
As vaccines are complex technologies that interact with the human body, their development is overseen by regulators in the administrative state. Countries structure the review of pharmaceutical products according to domestic rules and institutional design. As such, vaccines are reviewed as biologic products by regulatory authorities at the domestic level, such as the Therapeutic Goods Administration in Australia or the Pharmaceutical and Medical Devices Agency in Japan. The national basis of vaccine regulation inevitably leads to country-specific processes and timelines and may in some cases lead to different decisions.
Keywords
- Type
- Chapter
- Information
- Vaccines as TechnologyInnovation, Barriers, and the Public Health, pp. 26 - 55Publisher: Cambridge University PressPrint publication year: 2022